Food, Drugs, Healthcare, Life Sciences

O Ministério da Fazenda selecionou duas normas da ANVISA para análise de impacto concorrencial, abrindo uma janela estratégica para o setor farmacêutico influenciar a revisão das regras sobre venda remota de medicamentos e radiofármacos. As empresas têm até setembro de 2026 para apresentar contribuições que podem moldar o futuro regulatório do setor.

New regulations and technical adjustments expand compliance requirements, tighten safety criteria, and seek greater efficiency in regulatory processes and market access across Brazil's life sciences sector. This newsletter compiles the most critical regulatory updates affecting pharmaceuticals, supplementary health, food products, and other regulated sectors under ANVISA and professional councils.

Explore as principais mudanças normativas que impactam o setor agropecuário brasileiro, incluindo novas regras para aditivos antimicrobianos, cadastros de classificação, certificação fitossanitária, controle de máquinas agrícolas e regulamentação de termos de ajustamento de conduta para profissionais veterinários. Descubra como essas atualizações regulatórias afetam exportadores, importadores, produtores rurais e demais agentes da ca

New regulations and technical adjustments expand compliance requirements, tighten safety criteria, and seek greater efficiency in regulatory processes and market access across Brazil's life sciences sector. This newsletter compiles the most critical regulatory updates affecting pharmaceuticals, supplementary health, food products, and other regulated sectors under ANVISA and professional councils.

In April 2026, Mexico implemented a significant reform of its intellectual property legislation, with the objective to modernise the system, accelerate procedures and provide greater legal certainty to innovators.

Check recent decisions by regulatory agencies such as Anvisa and ANTT, as well as bills passed by Congress, that affect strategies and operations in regulated sectors...

O Ministério da Fazenda selecionou duas normas da ANVISA para análise de impacto concorrencial, abrindo uma janela estratégica para o setor farmacêutico influenciar a revisão das regras sobre venda remota de medicamentos e radiofármacos. As empresas têm até setembro de 2026 para apresentar contribuições que podem moldar o futuro regulatório do setor.

New regulations and technical adjustments expand compliance requirements, tighten safety criteria, and seek greater efficiency in regulatory processes and market access across Brazil's life sciences sector. This newsletter compiles the most critical regulatory updates affecting pharmaceuticals, supplementary health, food products, and other regulated sectors under ANVISA and professional councils.

In April 2026, Mexico implemented a significant reform of its intellectual property legislation, with the objective to modernise the system, accelerate procedures and provide greater legal certainty to innovators.